Skip to main content
SpringerLink
Log in

Clinically Relevant Vaccine-Vaccine Interactions

A Guide for Practitioners

  • Disease Management
  • Published:
BioDrugs Aims and scope Submit manuscript

Summary

The need for combination vaccines has been recognised for many years. Many children must have 9 or 12 injections in their first year, which places a considerable burden on the child and the health service. Combination vaccines or simultaneously administered vaccines need to generate a protective immune response to all vaccine components that is equivalent to the response when administered separately. This is not always the situation. Many vaccines should not be administered together because of adverse reactions known as vaccine-vaccine interactions, a phenomenon where one vaccine affects another vaccine, thus potentially causing loss of immunogenicity, loss of protective efficacy or induction of adverse reactions. It is important to remember that most vaccine-vaccine interactions are asymptomatic and may only be discovered when the immune status of the vaccine recipient is analysed or when the individual is challenged by the microbe. The interactions may occur because of physical or chemical interactions within the vaccine formulation, interactions between live vaccines or immunological interference. This review summarises known vaccine-vaccine interactions that have been critically analysed and categorised based on their clinical importance.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. D’Arcy PF. Vaccine-drug interactions. DICP 1984; 18: 697–700

    Google Scholar 

  2. Grabenstein JD. Drug interactions involving immunological agents. Part I. Vaccine-vaccine, vaccine-immunoglobulin, and vaccine-drug interactions. DICP 1990; 24: 67–81

    PubMed  CAS  Google Scholar 

  3. Gizurarson S. Optimal delivery of vaccines: clinical pharmacokinetic considerations. Clin Pharmacokinet 1996; 30: 1–15

    Article  PubMed  CAS  Google Scholar 

  4. Mitchell VS, Philipose NM, Sanford JP, et al. The children’s vaccine initiative: achieving the vision. Institute of Medicine. Washington DC: National Academy Press, 1993

    Google Scholar 

  5. Mulholland EK, Hoestermann A, Ward JI, et al. The use of Haemophilus influenzae type b-tetanus toxoid conjugate vaccine mixed with diphtheria-tetanus-pertussis vaccine in Gambian infants. Vaccine 1996; 14: 905–9

    Article  PubMed  CAS  Google Scholar 

  6. Deforest A, Long SS, Lischner HW, et al. Simultaneous administration of measles-mumps-rubella vaccine with booster doses of diphtheria-tetanus-pertussis and poliovirus vaccine. Pediatrics 1988; 81: 237–46

    PubMed  CAS  Google Scholar 

  7. Gammanco G, De Grandi V, Lupo L, et al. Interference of oral poliovirus vaccine on RIT 4237 oral rotavirus vaccine. Eur J Epidemiol 1988; 4: 121–3

    Article  Google Scholar 

  8. Insel RA. Potential alteration in immunogenicity by combining or simultaneously administering vaccine components. Ann NY Acad Sci 1995; 754: 35–47

    Article  PubMed  CAS  Google Scholar 

  9. Buynak EB, Weibel RE, Whitman JE, et al. Combined live measles, mumps, and rubella virus vaccine. JAMA 1969; 207: 2259–62

    Article  PubMed  CAS  Google Scholar 

  10. Ambrosch F, Fritzell B, Gregor J, et al. Combined vaccination against yellow fever and typhoid fever: a comparative trial. Vaccine 1994; 12: 625–8

    Article  PubMed  CAS  Google Scholar 

  11. Melnick JL. Live attenuated poliovirus vaccines. In: Plotkin SA, Mortimer EA, editors. Vaccines. 2nd ed. Philadelphia: WB Saunders Company, 1994: 155–204

    Google Scholar 

  12. Corbel MJ. Control testing of combined vaccines: a consideration of potential problems and approaches. Biologicals 1994; 22: 353–60

    Article  PubMed  CAS  Google Scholar 

  13. McGhee JR, Mestecky J, Dertzbaugh MT, et al. The mucosal immune system: from fundamental concepts to vaccine development. Vaccine 1992; 10: 75–88

    Article  PubMed  CAS  Google Scholar 

  14. Saldarin RJ. Strategies for developing combination vaccines. Ann NY Acad Sci 1995; 754: 17–22

    Article  Google Scholar 

  15. Galbraith NS, Crosby G, Barnes JM, et al. Simultaneous immunization with BCG, diphtheria-tetanus, and oral poliomyelitis vaccines in children aged 13–14. BMJ 1971; 2: 193–7

    Article  PubMed  CAS  Google Scholar 

  16. Labusquière R. Associated vaccines. Bull Int Union Tuberc 1973; 48: 53–5

    Google Scholar 

  17. Kaplan JE, Nelson DB, Schonberger LB, et al. The effect of immunoglobulin on the response to trivalent oral poliovirus and yellow-fever vaccinations. Bull World Health Organ 1984; 62: 585–90

    PubMed  CAS  Google Scholar 

  18. Felsenfeld O, Wolf RH, Gyr K, et al. Simultaneous vaccination against cholera and yellow fever. Lancet 1973; I: 457–8

    Article  Google Scholar 

  19. Gapochko KG, Vasilenko AZh, Misnikov OP, et al. The clinico-immunological validation of associated immunization. Voen Med Zh 1992 Mar; 3: 35–8

  20. Gapochko KG, Vasilenko AZh, Stepanov AV, et al. The experimental validation of associated immunization with paired combinations of vaccines. Voen Med Zh 1991 Sep; 9: 46–9

  21. Poveda JD, Raccurt CP, Le Fur R, et al. The inhibiting effect of anticholera vaccination carried out simultaneously or at short intervals on yellow fever immunization: is it real or assumed? Results of a retrospective study. Bull Soc Pathol Exot 1990; 83: 525–36

    Google Scholar 

  22. Gateff C, Dodin A, Wiart J. A comparison of the serological effects of classical cholera vaccine and of purified fraction vaccine, with or without simultaneous yellow fever vaccine. Ann Microbiol Paris 1975; 126: 231–46

    PubMed  CAS  Google Scholar 

  23. Ferreccio C, Clemens J, Avendano A, et al. The clinical and immunological response of Chilean infants to Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine coadministered in the same syringe with diphtheria-tetanus toxoids-pertussis vaccine at two, four and six months of age. Pediatr Infect Dis J 1991; 10: 764–71

    Article  PubMed  CAS  Google Scholar 

  24. Redhead K, Sesardic D, Yost SE, et al. Interaction of Haemophilus influenzae type b conjugate vaccines with diphtheria-tetanus-pertussis vaccine in control tests. Vaccine 1994; 12: 1460–6

    Article  PubMed  CAS  Google Scholar 

  25. Watemberg N, Dagan R, Arbelli Y, et al. Safety and immunogenicity of Haemophilus type b-tetanus protein conjugate vaccine, mixed in the same syringe with diphtheria-tetanus-pertussis vaccine in young infants. Pediatr Infect Dis J 1991; 10: 758–61

    Article  PubMed  CAS  Google Scholar 

  26. Paradiso PR, Hogerman DA, Madore DV, et al. Safety and immunogenicity of a combined diphtheria, tetanus, pertussis and Haemophilus influenzae type b vaccine in young infants. Pediatrics 1993; 92: 1–6

    Google Scholar 

  27. Avendano A, Ferrecio C, Lagos R, et al. Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine does not depress serological response to diphtheria tetanus or pertussis antigens when co-administered in the same syringe with diphtheria-tetanus-pertussis vaccine at two, four and six months of age. Pediatr Infect Dis J 1993; 12: 638–43

    Article  PubMed  CAS  Google Scholar 

  28. Clemens J, Brenner R, Rao M. Interactions between PRP-T vaccine against Haemophilus influenzae type b and conventional infant vaccines: lessons for future studies of simultaneous immunization and combined vaccines. Ann NY Acad Sci 1995; 754: 255–66

    Article  PubMed  CAS  Google Scholar 

  29. Lepow ML, Peter G, Glode MP, et al. Response of infants to Haemophilus influenzae type b polysaccharide and diphtheria-tetanus-pertussis vaccines in combination. J Infect Dis 1984; 149: 950–5

    Article  PubMed  CAS  Google Scholar 

  30. Clemens JD, Ferrecio C, Levine MM, et al. Impact of Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine on responses to concurrently administered diphtheria-tetanus-pertussis vaccine. JAMA 1992; 267: 673–8

    Article  PubMed  CAS  Google Scholar 

  31. Eskola J, Ölander R-M, Hovi T, et al. Randomised trial of the effect of co-administration with acellular pertussis DTP vaccine on immunogenicity of Haemophilus influenzae type b conjugate vaccine. Lancet 1996; 348: 1688–92

    Article  PubMed  CAS  Google Scholar 

  32. Edwards KM, Decker MD. Acellular pertussis vaccines for infants. N Engl J Med 1996; 334: 391–2

    Article  PubMed  CAS  Google Scholar 

  33. Zepp F, Knuf M, Habermehl P, et al. Pertussis-specific cell-mediated immunity in infants after vaccination with a tricomponent acellular pertussis vaccine. Infect Immun 1996; 64; 4078–84

    PubMed  CAS  Google Scholar 

  34. Schmitt HJ, Schuind A, Knuf M, et al. Clinical experience of a tricomponent acellular pertussis vaccine combined with diphtheria and tetanus toxoids for primary vaccination in 22,505 infants. J Pediatr 1996; 129: 695–701

    Article  PubMed  CAS  Google Scholar 

  35. Greco D, Salmaso S, Mastrantonio P, et al. Acontrolled trial of two acellular vaccines and one whole-cell vaccine against pertussis. N Engl J Med 1996; 334: 341–8

    Article  PubMed  CAS  Google Scholar 

  36. Paradiso PR. Combination vaccines for diphtheria, tetanus, pertussis, and Haemophilus influenzae type b. Ann NY Acad Sci 1995; 754: 108–113

    Article  PubMed  CAS  Google Scholar 

  37. Gold R, Scheifele D, Barreto L, et al. Safety and immunogenicity of Haemophilus influenzae vaccine (tetanus toxoid conjugate) administered concurrently or combined with diphtheria and tetanus toxoids, pertussis vaccine and inactivated polio-myelitis vaccine to healthy infants at two, four and six months of age. Pediatr Infect Dis J 1994; 13: 348–55

    Article  PubMed  CAS  Google Scholar 

  38. John JJ, Selvakumar R. Mixing measles vaccine with DPT and DPTP. Lancet 1985; I: 1154

    Article  Google Scholar 

  39. Ruben FL, Smith EA, Foster SO, et al. Simultaenous administration of smallpox, measles, yellow fever, and diphtheria-pertussis-tetanus antigens to Nigerian children. Bull World Health Organ 1973; 48: 175–81

    PubMed  CAS  Google Scholar 

  40. Mazert MC, Chabanier G, Adamowicz P, et al. Association of hepatitis B vaccine with other vaccines: laboratory animals study. Dev Biol Stand 1983; 54: 53–62

    PubMed  CAS  Google Scholar 

  41. Aristegui J, Muiz J, Perez-Legorburu A, et al. Newborn universal immunisation against hepatitis B: immunogenicity and reactogenicity of simultaneous administration of diphtheria/tetanus/pertussis (DTP) and oral polio vaccines with hepatitis B vaccine at 0, 2 and 6 months of age. Vaccine 1995; 13: 973–7

    Article  PubMed  CAS  Google Scholar 

  42. Da-Villa G, Picciotto L, Ribera G, et al. Effective antibody response in newborn babies living in Maldives to simultaneous vaccination against hepatitis B, poliomyelitis, diphtheria and tetanus. Vaccine 1995; 13: 795–8

    Article  PubMed  CAS  Google Scholar 

  43. Coursaget P, Yvonnet B, Relyveld EH, et al. Simultaneous administration of diphtheria/tetanus/pertussis/polio vaccine and hepatitis B vaccine in a simplified immunization programme. Dev Biol Stand 1986; 65: 169–75

    PubMed  CAS  Google Scholar 

  44. Coursaget P, Yvonnet B, Relyveld EH, et al. Simultaneous administration of diphtheria-tetanus-pertussis-polio and hepatitis B vaccine in a simplified immunization programme: immune response to diphtheria toxoid, tetanus toxoid, pertussis, and hepatitis B surface antigen. Infect Immun 1986; 51: 784–7

    PubMed  CAS  Google Scholar 

  45. Papaevangelou G, Karvelis E, Alexiou D, et al. Evaluation of a combined tetravalent diphtheria, tetanus, whole-cell pertussis and hepatitis B candidate vaccine administered to healthy infants according to a three-dose vaccination schedule. Vaccine 1995; 13: 175–8

    Article  PubMed  CAS  Google Scholar 

  46. Yvonnet B, Coursaget P, Deubel V, et al. Simultaneous administration of hepatitis B and yellow fever vaccines. Dev Biol Stand 1986; 65: 205–7

    PubMed  CAS  Google Scholar 

  47. Wright PF, Okabe N, McKee Jr KT, et al. Cold-adapted recombinant influenza A virus vaccines in seronegative young children. J Infect Dis 1982; 146: 71–9

    Article  PubMed  CAS  Google Scholar 

  48. Wright PF, Bahragava M, Johnson PR, et al. Simultaneous administration of live attenuated influenza A vaccines representing different serotypes. Vaccine 1985; 3: 305–8

    Article  PubMed  CAS  Google Scholar 

  49. Belshe RB, Anderson EL, Newman F, et al. Immunization of infants and young children with live attenuated trivalent cold recombinant influenza AH1N1, H3N2 and B vaccine. J Infect Dis 1992; 165: 727–32

    Article  PubMed  CAS  Google Scholar 

  50. Honkanen PO, Keistinen T, Kivela SL. Reactions following administration of influenza vaccine alone or with pneumococcal vaccine to the elderly. Arch Intern Med 1996; 156: 205–8

    Article  PubMed  CAS  Google Scholar 

  51. Hilleman RM, Carlson AJ, McLean AA, et al. Streptococcus pneumoniae polysaccharide vaccine: age and dose responses, safety, persistence of antibody, revaccination, and simultaneous administration of pneumococcal and influenza vaccines. Rev Infect Dis 1981; 3 Suppl.: S31–42

    Article  PubMed  Google Scholar 

  52. McCue JD. Adverse reactions to simultaneous influenza and pneumococcal vaccination. J Fam Pract 1981; 13: 175–7

    PubMed  CAS  Google Scholar 

  53. Mufson MA, Krause HE, Tarrant CJ, et al. Polyvalent pneumococcal vaccine given alone and in combination with bivalent influenza virus vaccine. Proc Soc Exp Biol Med 1980; 163: 498–503

    PubMed  CAS  Google Scholar 

  54. Houston TP. Small-vessel vasculitits following simultaneous influenza and pneumococcal vaccination. NY State J Med 1983; 83: 1182–3

    CAS  Google Scholar 

  55. Bentley DW. Vaccinations. Clin Geriatr Med 1992; 8: 745–60

    PubMed  CAS  Google Scholar 

  56. Ajjan N, Fayet MTh, Biron G, et al. combination of attenuated measles vaccine (Schwarz) with meningococcus A and A+C vaccine. Dev Biol Stand 1978; 41: 209–19

    PubMed  CAS  Google Scholar 

  57. Karchmer AW, Friedman JP, Casey HL, et al. Simultaneous administration of live virus vaccines: measles, mumps, polio-myelitis, and smallpox. Am J Dis Child 1971; 121: 382–8

    PubMed  CAS  Google Scholar 

  58. Fulginiti VA, editor. Immunization in clinical practice. Philadelphia: JB Lippincott, 1982: 145–50

    Google Scholar 

  59. Weibel RE, Stokes Jr J, Buynak EB, et al. Clinical-laboratory experiences with combined dried live measles-smallpox vaccine. Pediatrics 1966; 37: 913–20

    PubMed  CAS  Google Scholar 

  60. Meyer Jr HM, Hostetler Jr DD, Bernheim BC, et al. Response of Volta children to jet inoculation of combined live measles, smallpox, and yellow-fever vaccines. Bull World Health Organ 1964; 30: 783–94

    PubMed  Google Scholar 

  61. Henderson DA, Fenner F. Smallpox and vaccinia. In: Plotkin SA, Mortimer EA, editors. Vaccines 2nd ed. Philadelphia: WB Saunders Company, 1994: 13–40

    Google Scholar 

  62. Migasena S, Simasathien S, Samakoses R, et al. Simultaneous administration of oral rhesus-human reassortant tetravalent (RRV-TV) rotavirus vaccine and oral poliovirus vaccine (OPV) in Thai infants. Vaccine 1995; 13: 168–74

    Article  PubMed  CAS  Google Scholar 

  63. Ho M-S, Floyd RL, Glass RI, et al. Simultaneous administration of rhesus rotavirus vaccine and oral poliovirus vaccine: immunogenicity and reactogenicity. Pediatr Infect Dis J 1989; 8: 692–6

    Article  PubMed  CAS  Google Scholar 

  64. Parkman PD. Combined and simultaneously administered vaccines: a brief history. Ann NY Acad Sci 1995; 754: 1–9

    Article  PubMed  CAS  Google Scholar 

  65. Chen RT, Haber P, Mullen JR. Surveillance of the safety of simultaneous administration of vaccines. Ann NY Acad Sci 1995; 754: 309–20

    Article  PubMed  CAS  Google Scholar 

  66. Arbeter AM, Starr SE, Plotkin SA. Varicella vaccine studies in healthy children and adults. Pediatrics 1986; 78 Suppl.: 748–56

    PubMed  CAS  Google Scholar 

  67. Gizurarson S, Aggerbeck H, Heron I. Non-ionic surfactants and mono-/diglycerides as mucosal adjuvants for intranasal vaccination of humans [abstract]. Mucosal Immunol Update 1996; 4: 33

    Google Scholar 

  68. Aprile MA, Warklaw AC. Aluminium compounds as adjuvants for vaccines and toxoids in man: a review. Can J Public Health 1966; 57: 343–54

    PubMed  CAS  Google Scholar 

  69. Madore DV. Progress and challenges for a new combination vaccine composed of diphtheria, tetanus, acellular pertussis, and Haemophilus b conjugate. Ann NY Acad Sci 1995; 754: 356–8

    Article  PubMed  CAS  Google Scholar 

  70. Halperin SA, Eastwood BJ, Barreto L, et al. Adverse reactions and antibody response to four doses of acellular or whole cell pertussis vaccine combined with diphtheria and tetanus toxoids in the first 19 months of life. Vaccine 1996; 14: 767–72

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacy, University of Iceland, PO Box 7171, 127 Reykjavik, Iceland

    Sveinbjörn Gizurarson

Authors
  1. Sveinbjörn Gizurarson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sveinbjörn Gizurarson.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gizurarson, S. Clinically Relevant Vaccine-Vaccine Interactions. BioDrugs 9, 443–453 (1998). https://doi.org/10.2165/00063030-199809060-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00063030-199809060-00002

Keywords

Search

Navigation